6726 - 6750 of 7939 Results
Title
Year
-
OPENTitle: Parkinson's disease biomarkers program brain imaging repositoryJournal Name: NeuroImagePublisher: Elsevier BVVol: 124Issue #:Start Page: 1120End Page: 1124Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2015.05.005Best OA location URL: https://europepmc.org/articles/pmc4643422?pdf=renderCitation Count: 18
-
RESTRICTEDTitle: Cellular processes associated with LRRK2 function and dysfunctionJournal Name: The FEBS JournalPublisher: WileyVol: 282Issue #: 15Start Page: 2806End Page: 2826Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1111/febs.13305Best OA location URL: https://doi.org/10.1111/febs.13305Citation Count: 133
- Hippocampal (subfield) volume and shape in relation to cognitive performance across the adult lifespan2015OPENTitle: Hippocampal (subfield) volume and shape in relation to cognitive performance across the adult lifespanJournal Name: Human Brain MappingPublisher: WileyVol: 36Issue #: 8Start Page: 3020End Page: 3037Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.22825Best OA location URL: https://europepmc.org/articles/pmc6869683?pdf=renderCitation Count: 91
- Disclosure of research results in genetic studies of Parkinson's disease caused byLRRK2mutations2015OPENTitle: Disclosure of research results in genetic studies of Parkinson's disease caused byLRRK2mutationsJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 7Start Page: 904End Page: 908Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26250Best OA location URL: https://europepmc.org/articles/pmc4478096?pdf=renderCitation Count: 10
-
OPENTitle: Aberrant cerebral network topology and mild cognitive impairment in early Parkinson's diseaseJournal Name: Human Brain MappingPublisher: WileyVol: 36Issue #: 8Start Page: 2980End Page: 2995Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.22822Best OA location URL: https://europepmc.org/articles/pmc6869566?pdf=renderCitation Count: 99
-
OPENTitle: Novel recruitment strategy to enrich forLRRK2mutation carriersJournal Name: Molecular Genetics & Genomic MedicinePublisher: WileyVol: 3Issue #: 5Start Page: 404End Page: 412Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mgg3.151Best OA location URL: https://doi.org/10.1002/mgg3.151Citation Count: 17
- Structural and Functional Impact of Parkinson Disease-Associated Mutations in the E3 Ubiquitin Ligase Parkin2015OPENTitle: Structural and Functional Impact of Parkinson Disease-Associated Mutations in the E3 Ubiquitin Ligase ParkinJournal Name: Human MutationPublisher: WileyVol: 36Issue #: 8Start Page: 774End Page: 786Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/humu.22808Best OA location URL: https://europepmc.org/articles/pmc4514554?pdf=renderCitation Count: 80
- Dopamine receptors D3 and D5 regulate CD4+T-cell activation and differentiation by modulating ERK activation and cAMP production2015RESTRICTEDTitle: Dopamine receptors D3 and D5 regulate CD4+T-cell activation and differentiation by modulating ERK activation and cAMP productionJournal Name: Journal of NeuroimmunologyPublisher: Elsevier BVVol: 284Issue #:Start Page: 18End Page: 29Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jneuroim.2015.05.003Citation Count: 44
-
RESTRICTEDTitle: Emerging mechanisms of molecular pathology in ALSJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 125Issue #: 5Start Page: 1767End Page: 1779Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1172/jci71601Best OA location URL: http://www.jci.org/articles/view/71601/files/pdfCitation Count: 240
-
RESTRICTEDTitle: Novel Methods and Technologies for 21st-Century Clinical TrialsJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 72Issue #: 5Start Page: 582End Page: 582Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.4524Best OA location URL: https://europepmc.org/articles/pmc4708881?pdf=renderCitation Count: 92
- Dopaminergic Lesions of the Dorsolateral Striatum in Rats Increase Delay Discounting in an Impulsive Choice Task2015OPENTitle: Dopaminergic Lesions of the Dorsolateral Striatum in Rats Increase Delay Discounting in an Impulsive Choice TaskJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 10Issue #: 4Start Page: e0122063End Page: e0122063Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0122063Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0122063&type=printableCitation Count: 55
-
OPENTitle: Potential sex differences in nonmotor symptoms in early drug-naive Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 84Issue #: 21Start Page: 2107End Page: 2115Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000001609Best OA location URL: https://europepmc.org/articles/pmc4451049?pdf=renderCitation Count: 97
-
OPENTitle: Diffusion tensor imaging of the nigrostriatal fibers in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 9Start Page: 1229End Page: 1236Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26251Best OA location URL: https://europepmc.org/articles/pmc4418199?pdf=renderCitation Count: 97
- The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease2015RESTRICTEDTitle: The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 11Issue #: 12Start Page: 1407End Page: 1416Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2014.12.009Best OA location URL: https://pure.mpg.de/pubman/item/item_2240814_9/component/file_2240812/id10000739.pdfCitation Count: 153
-
OPENTitle: Targeting β-arrestin2 in the treatment of l -DOPA–induced dyskinesia in Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 112Issue #: 19Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1502740112Best OA location URL: https://www.pnas.org/content/pnas/112/19/E2517.full.pdfCitation Count: 96
- Identification of rare protein disulfide isomerase gene variants in amyotrophic lateral sclerosis patients2015OPENTitle: Identification of rare protein disulfide isomerase gene variants in amyotrophic lateral sclerosis patientsJournal Name: GenePublisher: Elsevier BVVol: 566Issue #: 2Start Page: 158End Page: 165Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.gene.2015.04.035Best OA location URL: https://europepmc.org/articles/pmc5553116?pdf=renderCitation Count: 70
-
RESTRICTEDTitle: Impact of Parkinson's disease risk loci on age at onsetJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 6Start Page: 847End Page: 850Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26237Citation Count: 46
-
OPENTitle: Differential involvement of Ras‐GRF1 and Ras‐GRF2 in L‐DOPA‐induced dyskinesiaJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 2Issue #: 6Start Page: 662End Page: 678Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.202Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.202Citation Count: 20
- Common genetic variant association with altered HLA expression, synergy with pyrethroid exposure, and risk for Parkinson’s disease: an observational and case–control study2015OPENTitle: Common genetic variant association with altered HLA expression, synergy with pyrethroid exposure, and risk for Parkinson’s disease: an observational and case–control studyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 1Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/npjparkd.2015.2Best OA location URL: https://www.nature.com/articles/npjparkd20152.pdfCitation Count: 119
-
OPENTitle: Structural Characterization of LRRK2 InhibitorsJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 58Issue #: 9Start Page: 3751End Page: 3756Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jm5018779Best OA location URL: https://pure.rug.nl/ws/files/85554165/Structural_Characterization_of_LRRK2_Inhibitors.pdfCitation Count: 37
-
OPENTitle: Classification of pallidal oscillations with increasing parkinsonian severityJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 114Issue #: 1Start Page: 209End Page: 218Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1152/jn.00840.2014Best OA location URL: https://europepmc.org/articles/pmc4507953Citation Count: 21
-
RESTRICTEDTitle: LRRK2 mutations and neurotoxicant susceptibilityJournal Name: Experimental Biology and MedicinePublisher: Frontiers Media SAVol: 240Issue #: 6Start Page: 752End Page: 759Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/1535370215579162Best OA location URL: https://europepmc.org/articles/pmc4935210?pdf=renderCitation Count: 28
- Therapeutic deep brain stimulation reduces cortical phase-amplitude coupling in Parkinson's disease2015OPENTitle: Therapeutic deep brain stimulation reduces cortical phase-amplitude coupling in Parkinson's diseaseJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 18Issue #: 5Start Page: 779End Page: 786Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nn.3997Best OA location URL: https://europepmc.org/articles/pmc4414895?pdf=renderCitation Count: 560
- Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and function2015RESTRICTEDTitle: Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and functionJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 78Issue #:Start Page: 100End Page: 114Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2015.03.008Citation Count: 23
- Increased 14-3-3 phosphorylation observed in Parkinson's disease reduces neuroprotective potential of 14-3-3 proteins2015OPENTitle: Increased 14-3-3 phosphorylation observed in Parkinson's disease reduces neuroprotective potential of 14-3-3 proteinsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 79Issue #:Start Page: 1End Page: 13Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2015.02.032Best OA location URL: https://europepmc.org/articles/pmc4458424?pdf=renderCitation Count: 37